These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 9504387

  • 1. State-dependent NMDA receptor antagonism by Ro 8-4304, a novel NR2B selective, non-competitive, voltage-independent antagonist.
    Kew JN, Trube G, Kemp JA.
    Br J Pharmacol; 1998 Feb; 123(3):463-72. PubMed ID: 9504387
    [Abstract] [Full Text] [Related]

  • 2. Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission.
    Frizelle PA, Chen PE, Wyllie DJ.
    Mol Pharmacol; 2006 Sep; 70(3):1022-32. PubMed ID: 16778008
    [Abstract] [Full Text] [Related]

  • 3. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors.
    Williams K.
    Mol Pharmacol; 1993 Oct; 44(4):851-9. PubMed ID: 7901753
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological characterization of Ro 63-1908 (1-[2-(4-hydroxy-phenoxy)-ethyl]-4-(4-methyl-benzyl)-piperidin-4-ol), a novel subtype-selective N-methyl-D-aspartate antagonist.
    Gill R, Alanine A, Bourson A, Buttelmann B, Fischer G, Heitz MP, Kew JN, Levet-Trafit B, Lorez HP, Malherbe P, Miss MT, Mutel V, Pinard E, Roever S, Schmitt M, Trube G, Wybrecht R, Wyler R, Kemp JA.
    J Pharmacol Exp Ther; 2002 Sep; 302(3):940-8. PubMed ID: 12183650
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells.
    Priestley T, Laughton P, Myers J, Le Bourdellés B, Kerby J, Whiting PJ.
    Mol Pharmacol; 1995 Nov; 48(5):841-8. PubMed ID: 7476914
    [Abstract] [Full Text] [Related]

  • 6. Ro 25-6981, a highly potent and selective blocker of N-methyl-D-aspartate receptors containing the NR2B subunit. Characterization in vitro.
    Fischer G, Mutel V, Trube G, Malherbe P, Kew JN, Mohacsi E, Heitz MP, Kemp JA.
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1285-92. PubMed ID: 9400004
    [Abstract] [Full Text] [Related]

  • 7. A novel mechanism of activity-dependent NMDA receptor antagonism describes the effect of ifenprodil in rat cultured cortical neurones.
    Kew JN, Trube G, Kemp JA.
    J Physiol; 1996 Dec 15; 497 ( Pt 3)(Pt 3):761-72. PubMed ID: 9003561
    [Abstract] [Full Text] [Related]

  • 8. An allosteric interaction between the NMDA receptor polyamine and ifenprodil sites in rat cultured cortical neurones.
    Kew JN, Kemp JA.
    J Physiol; 1998 Oct 01; 512 ( Pt 1)(Pt 1):17-28. PubMed ID: 9729614
    [Abstract] [Full Text] [Related]

  • 9. Use of trifluoroperazine isolates a [(3)H]Ifenprodil binding site in rat brain membranes with the pharmacology of the voltage-independent ifenprodil site on N-methyl-D-aspartate receptors containing NR2B subunits.
    Coughenour LL, Barr BM.
    J Pharmacol Exp Ther; 2001 Jan 01; 296(1):150-9. PubMed ID: 11123375
    [Abstract] [Full Text] [Related]

  • 10. In vitro characterization of novel NR2B selective NMDA receptor antagonists.
    Kiss L, Cheng G, Bednar B, Bednar RA, Bennett PB, Kane SA, McIntyre CJ, McCauley JA, Koblan KS.
    Neurochem Int; 2005 May 01; 46(6):453-64. PubMed ID: 15769547
    [Abstract] [Full Text] [Related]

  • 11. Antagonism of N-methyl-D-aspartate receptors by sigma site ligands: potency, subtype-selectivity and mechanisms of inhibition.
    Whittemore ER, Ilyin VI, Woodward RM.
    J Pharmacol Exp Ther; 1997 Jul 01; 282(1):326-38. PubMed ID: 9223571
    [Abstract] [Full Text] [Related]

  • 12. Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.
    Ilyin VI, Whittemore ER, Guastella J, Weber E, Woodward RM.
    Mol Pharmacol; 1996 Dec 01; 50(6):1541-50. PubMed ID: 8967976
    [Abstract] [Full Text] [Related]

  • 13. Identification of critical residues in the amino terminal domain of the human NR2B subunit involved in the RO 25-6981 binding pocket.
    Malherbe P, Mutel V, Broger C, Perin-Dureau F, Kemp JA, Neyton J, Paoletti P, Kew JN.
    J Pharmacol Exp Ther; 2003 Dec 01; 307(3):897-905. PubMed ID: 14534359
    [Abstract] [Full Text] [Related]

  • 14. Enhancement of NMDA-induced current by the putative NR2B selective antagonist ifenprodil.
    Zhang XX, Bunney BS, Shi WX.
    Synapse; 2000 Jul 01; 37(1):56-63. PubMed ID: 10842351
    [Abstract] [Full Text] [Related]

  • 15. The effect of CGX-1007 and CI-1041, novel NMDA receptor antagonists, on NMDA receptor-mediated EPSCs.
    Barton ME, White HS, Wilcox KS.
    Epilepsy Res; 2004 Mar 01; 59(1):13-24. PubMed ID: 15135163
    [Abstract] [Full Text] [Related]

  • 16. Excitatory amino acid receptors of the electrosensory system: the NR1/NR2B N-methyl-D-aspartate receptor.
    Harvey-Girard E, Dunn RJ.
    J Neurophysiol; 2003 Feb 01; 89(2):822-32. PubMed ID: 12574460
    [Abstract] [Full Text] [Related]

  • 17. Characterization of haloperidol and trifluperidol as subtype-selective N-methyl-D-aspartate (NMDA) receptor antagonists using [3H]TCP and [3H]ifenprodil binding in rat brain membranes.
    Coughenour LL, Cordon JJ.
    J Pharmacol Exp Ther; 1997 Feb 01; 280(2):584-92. PubMed ID: 9023267
    [Abstract] [Full Text] [Related]

  • 18. N-methyl-D-aspartate autoreceptors respond to low and high agonist concentrations by facilitating, respectively, exocytosis and carrier-mediated release of glutamate in rat hippocampus.
    Luccini E, Musante V, Neri E, Raiteri M, Pittaluga A.
    J Neurosci Res; 2007 Dec 01; 85(16):3657-65. PubMed ID: 17671992
    [Abstract] [Full Text] [Related]

  • 19. The novel NMDA receptor antagonist, 2-hydroxy-5-(2,3,5,6-tetrafluoro-4-trifluoromethyl-benzylamino)-benzoic acid, is a gating modifier in cultured mouse cortical neurons.
    Noh J, Lee ES, Chung JM.
    J Neurochem; 2009 Jun 01; 109(5):1261-71. PubMed ID: 19302475
    [Abstract] [Full Text] [Related]

  • 20. Native N-methyl-D-aspartate receptors containing NR2A and NR2B subunits have pharmacologically distinct competitive antagonist binding sites.
    Christie JM, Jane DE, Monaghan DT.
    J Pharmacol Exp Ther; 2000 Mar 01; 292(3):1169-74. PubMed ID: 10688637
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.